Ajax is targeting hematologic malignancies with greater precision by applying state-of-the-art computational chemistry and structural biology throughout the drug discovery and development process to create best-in-class therapies for significant unmet medical needs.

Biotechnology

Ajax Therapeutics

Ajax Therapeutics' headquarters in New York, NY, United States

Martin Vogelbaum

Christine Richardson

Craig E. Masse

Ramy Farid

Scott Platshon

Ross Levine

Eric S. Fischer

Ajax Therapeutics' Leadership Team includes Craig E. Masse and 2 others.

About

People (2)

Craig E. Masse

Martin Vogelbaum

Jobs